234 related articles for article (PubMed ID: 16700821)
1. Steady state pharmacokinetics of oral treatment with 13-cis-retinoic acid or all-trans-retinoic acid in male and female adult rats.
Ferguson SA; Siitonen PH; Cisneros FJ; Gough B; Young JF
Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):582-7. PubMed ID: 16700821
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of albumin, triglycerides, total protein and glucose in rats are altered after oral treatment with low doses of 13-cis-retinoic acid or all-trans-retinoic acid.
Cisneros FJ; Gough BJ; Patton RE; Ferguson SA
J Appl Toxicol; 2005; 25(6):470-8. PubMed ID: 16092084
[TBL] [Abstract][Full Text] [Related]
3. Comparative teratology and transplacental pharmacokinetics of all-trans-retinoic acid, 13-cis-retinoic acid, and retinyl palmitate following daily administrations in rats.
Collins MD; Tzimas G; Hummler H; Bürgin H; Nau H
Toxicol Appl Pharmacol; 1994 Jul; 127(1):132-44. PubMed ID: 8048045
[TBL] [Abstract][Full Text] [Related]
4. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid.
Tzimas G; Nau H; Hendrickx AG; Peterson PE; Hummler H
Teratology; 1996 Nov; 54(5):255-65. PubMed ID: 9035347
[TBL] [Abstract][Full Text] [Related]
5. Oral Accutane (13-cis-retinoic acid) has no effects on spatial learning and memory in male and female Sprague-Dawley rats.
Ferguson SA; Berry KJ
Neurotoxicol Teratol; 2007; 29(2):219-27. PubMed ID: 17161936
[TBL] [Abstract][Full Text] [Related]
6. Oral treatment with ACCUTANE does not increase measures of anhedonia or depression in rats.
Ferguson SA; Cisneros FJ; Hanig JP; Berry KJ
Neurotoxicol Teratol; 2007; 29(6):642-51. PubMed ID: 17933491
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of all-trans retinoic acid, 13-cis retinoic acid, and fenretinide in plasma and brain of Rat.
Le Doze F; Debruyne D; Albessard F; Barre L; Defer GL
Drug Metab Dispos; 2000 Feb; 28(2):205-8. PubMed ID: 10640519
[TBL] [Abstract][Full Text] [Related]
8. Teratogenicity and transplacental pharmacokinetics of 13-cis-retinoic acid in rabbits.
Eckhoff C; Chari S; Kromka M; Staudner H; Juhasz L; Rudiger H; Agnish N
Toxicol Appl Pharmacol; 1994 Mar; 125(1):34-41. PubMed ID: 8128493
[TBL] [Abstract][Full Text] [Related]
9. UV-induced isomerization of oral retinoids in vitro and in vivo in hairless mice.
Berne B; Rollman O; Vahlquist A
Photodermatol Photoimmunol Photomed; 1990 Aug; 7(4):146-52. PubMed ID: 2150173
[TBL] [Abstract][Full Text] [Related]
10. Plasma pharmacokinetics and metabolism of 13-cis- and all-trans-retinoic acid in the cynomolgus monkey and the identification of 13-cis- and all-trans-retinoyl-beta-glucuronides. A comparison to one human case study with isotretinoin.
Kraft JC; Slikker W; Bailey JR; Roberts LG; Fischer B; Wittfoht W; Nau H
Drug Metab Dispos; 1991; 19(2):317-24. PubMed ID: 1676630
[TBL] [Abstract][Full Text] [Related]
11. Chronic oral treatment with 13-cis-retinoic acid (isotretinoin) or all-trans-retinoic acid does not alter depression-like behaviors in rats.
Ferguson SA; Cisneros FJ; Gough B; Hanig JP; Berry KJ
Toxicol Sci; 2005 Oct; 87(2):451-9. PubMed ID: 16033993
[TBL] [Abstract][Full Text] [Related]
12. Single versus multiple dose administration of all-trans-retinoic acid during organogenesis: differential metabolism and transplacental kinetics in rat and rabbit.
Collins MD; Tzimas G; Bürgin H; Hummler H; Nau H
Toxicol Appl Pharmacol; 1995 Jan; 130(1):9-18. PubMed ID: 7839374
[TBL] [Abstract][Full Text] [Related]
13. Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid.
Nau H
J Am Acad Dermatol; 2001 Nov; 45(5):S183-7. PubMed ID: 11606951
[TBL] [Abstract][Full Text] [Related]
14. Maternal toxicokinetics, metabolism, and embryo exposure following a teratogenic dosing regimen with 13-cis-retinoic acid (isotretinoin) in the cynomolgus monkey.
Hummler H; Hendrickx AG; Nau H
Teratology; 1994 Sep; 50(3):184-93. PubMed ID: 7871482
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of 13-cis-, all-trans-, 13-cis-4-oxo-, and all-trans-4-oxo retinoic acid after intravenous administration in the cynomolgus monkey.
Sandberg JA; Eckhoff C; Nau H; Slikker W
Drug Metab Dispos; 1994; 22(1):154-60. PubMed ID: 8149876
[TBL] [Abstract][Full Text] [Related]
16. Oxidative and reductive metabolism of 9-cis-retinoic acid in the rat. Identification of 13,14-dihydro-9-cis-retinoic acid and its taurine conjugate.
Shirley MA; Bennani YL; Boehm MF; Breau AP; Pathirana C; Ulm EH
Drug Metab Dispos; 1996 Mar; 24(3):293-302. PubMed ID: 8820419
[TBL] [Abstract][Full Text] [Related]
17. Correlations between conceptal concentrations of all-trans-retinoic acid and dysmorphogenesis after microinjections of all-trans-retinoic acid, 13-cis-retinoic acid, all-trans-retinoyl-beta-glucuronide, or retinol in cultured whole rat embryos.
Kraft JC; Juchau MR
Drug Metab Dispos; 1992; 20(2):218-25. PubMed ID: 1352213
[TBL] [Abstract][Full Text] [Related]
18. Oral treatment with retinoic acid decreases bone mass in rats.
Hotchkiss CE; Latendresse J; Ferguson SA
Comp Med; 2006 Dec; 56(6):502-11. PubMed ID: 17219781
[TBL] [Abstract][Full Text] [Related]
19. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice.
Achkar CC; Bentel JM; Boylan JF; Scher HI; Gudas LJ; Miller WH
Drug Metab Dispos; 1994; 22(3):451-8. PubMed ID: 8070324
[TBL] [Abstract][Full Text] [Related]
20. All-trans-retinoic acid in maternal plasma and teratogenicity in rats and rabbits.
Tembe EA; Honeywell R; Buss NE; Renwick AG
Toxicol Appl Pharmacol; 1996 Dec; 141(2):456-72. PubMed ID: 8975771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
